Thursday , May 25 2017
Home / Blog

Blog

The 2017 Hepatitis C Treatment Landscape

Last year, 2016, brought a whirlwind of changes and progress to the hepatitis C field, particularly when it comes to direct-acting antiviral medications. This included various drug approvals and access improvements for hepatitis C medications, including Daklinza, Epclusa, Sovaldi/velpatasvir, Viekira, and Zepatier. As we make our way deeper into 2017, …

Read More »

Potential New Medication for Lymphoma

The medication Imbruvica® (ibrutinib) from AbbVie first gained FDA approval in 2013 for treating mantle cell lymphoma, then in 2014 the approval was expanded to include chronic lymphocytic leukemia. The next year, 2015, Waldenstrom’s macroglobulinemia was added to the FDA approvals for this medication. Now, in 2017, Imbruvica has been …

Read More »

Get Moving for GI Cancers

Finding an activity that one can do regularly – whether that’s walking, playing basketball, cycling, or anything else that raises heart rates and moves big muscle groups – brings health benefits in a variety of ways. Lowering the risk of cancer is one such benefit, particularly when it comes to …

Read More »

HCV: Relapse or Reinfection?

Today’s hepatitis C medications offer extremely high cure rates. In fact, the few cases of a previously treated patient later testing positive for hepatitis C has some patients wondering “did I relapse or could I have been reinfected?” There are six different genotypes of the hepatitis C virus (as well …

Read More »

Facing Down Crohn’s and Related Diseases

Inflammatory bowel disease – which includes both Crohn’s disease and ulcerative colitis – affects 1.6 million Americans, a number that continues to rise. Each year, the U.S. sees 70,000 new cases diagnosed. Although a cure remains elusive, these chronic and life-long diseases can be treated with a variety of treatment …

Read More »

Psoriasis and Skin Cancer

The autoimmune skin disease called psoriasis tends to be associated with other health concerns, including diabetes, heart disease, and depression. Unfortunately, yet another disease is being added to this list: melanoma. Early research investigating the potential link between psoriasis and skin cancer were unclear as to whether the psoriasis or …

Read More »

Let’s Screen Everyone

Too many people infected with the hepatitis C virus (HCV) simply don’t know their disease status. As many as one in four cases of HCV infection are undiagnosed, as I pointed out in a blog earlier this year (Finding the Missing Cases), even when current federal guidelines for hepatitis C …

Read More »

Coffee: Pour Another Cup, Guilt-Free

Coffee is not only a welcome way that 54% of Americans start their day, it also offers liver benefits to coffee fans. I have shared good news about coffee and liver health in several past blogs, including last year’s The Buzz of Caffeine in which coffee’s ability to protect against …

Read More »

PSA: The Prostate Cancer Screening Test

Prostate cancer is the second most common cancer in American men, following skin cancer. One in every seven men will be diagnosed with this form of cancer in his lifetime; with the average age of diagnosis being age 66. In terms of fatalities, only lung cancer comes with a higher …

Read More »